2022 Q4 Form 10-Q Financial Statement

#000121390022071147 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $10.45M $9.550M
YoY Change 112.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.771M $7.222M
YoY Change 135.31%
Operating Profit -$9.521M -$6.948M
YoY Change 140.07%
Interest Expense $7.016M
YoY Change 260.98%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$6.756M -$65.33M
YoY Change
Net Earnings / Revenue -64.63% -684.14%
Basic Earnings Per Share -$0.29 -$2.85
Diluted Earnings Per Share -$0.29 -$2.85
COMMON SHARES
Basic Shares Outstanding 23.06M shares 23.21M shares 22.93M shares
Diluted Shares Outstanding 23.21M shares 22.93M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.651M $4.181M $99.03K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.057B $1.020B
YoY Change -13.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $694.0M $646.0M
YoY Change -9.22%
SHAREHOLDERS EQUITY
Retained Earnings -$110.5M -$86.07M
YoY Change -1475.21%
Common Stock $24.29K $23.37K
YoY Change 7.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $363.4M $373.9M $385.4M
YoY Change
Total Liabilities & Shareholders Equity $1.057B $1.020B
YoY Change -13.13%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$6.756M -$65.33M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56126
dei Entity Registrant Name
EntityRegistrantName
Palmer Square Capital BDC Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3665200
dei Entity Address Address Line1
EntityAddressAddressLine1
1900 Shawnee Mission Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 315
dei Entity Address City Or Town
EntityAddressCityOrTown
Mission Woods
dei Entity Address State Or Province
EntityAddressStateOrProvince
KS
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
66205
dei City Area Code
CityAreaCode
(816)
dei Local Phone Number
LocalPhoneNumber
994-3200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23062349 shares
CY2022Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1103805969 usd
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1189713653 usd
CY2022Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1005512911 usd
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1194257584 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4180777 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1093503 usd
CY2022Q3 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
637657 usd
CY2021Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
17393877 usd
CY2022Q3 cik0001794776 Receivable For Paydowns Of Investments
ReceivableForPaydownsOfInvestments
3190785 usd
CY2021Q4 cik0001794776 Receivable For Paydowns Of Investments
ReceivableForPaydownsOfInvestments
227548 usd
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
250013 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
280740 usd
CY2022Q3 us-gaap Dividends Receivable
DividendsReceivable
99904 usd
CY2021Q4 us-gaap Dividends Receivable
DividendsReceivable
833 usd
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
5654159 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
3836068 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
400695 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
195996 usd
CY2022Q3 us-gaap Assets
Assets
1019926901 usd
CY2021Q4 us-gaap Assets
Assets
1217286149 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
637078714 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
649910497 usd
CY2022Q3 cik0001794776 Payable For Investments Purchased
PayableForInvestmentsPurchased
6084500 usd
CY2021Q4 cik0001794776 Payable For Investments Purchased
PayableForInvestmentsPurchased
104278958 usd
CY2021Q4 cik0001794776 Distributions Payable
DistributionsPayable
5874681 usd
CY2022Q3 us-gaap Management Fee Payable
ManagementFeePayable
2000103 usd
CY2021Q4 us-gaap Management Fee Payable
ManagementFeePayable
2245918 usd
CY2022Q3 cik0001794776 Directors Fees Payable
DirectorsFeesPayable
4486 usd
CY2021Q4 cik0001794776 Directors Fees Payable
DirectorsFeesPayable
5000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
850331 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2173507 usd
CY2022Q3 us-gaap Liabilities
Liabilities
646018134 usd
CY2021Q4 us-gaap Liabilities
Liabilities
764488561 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23373787 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23373787 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22570331 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22570331 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
23374 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
22570 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
459956116 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
444739748 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86070723 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8035270 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
373908767 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
452797588 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1019926901 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1217286149 usd
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.06
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
19718478 usd
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8722685 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
50266810 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
25917343 usd
CY2022Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
223816 usd
CY2021Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2775 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
278529 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
5412 usd
CY2022Q3 us-gaap Other Income
OtherIncome
31260 usd
CY2021Q3 us-gaap Other Income
OtherIncome
150489 usd
us-gaap Other Income
OtherIncome
180415 usd
us-gaap Other Income
OtherIncome
497298 usd
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
19973554 usd
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
8875949 usd
us-gaap Investment Income Net
InvestmentIncomeNet
50725754 usd
us-gaap Investment Income Net
InvestmentIncomeNet
26420053 usd
CY2022Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
19973554 usd
CY2021Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8875949 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
50725754 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26420053 usd
us-gaap Management Fee Expense
ManagementFeeExpense
6455899 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
7015768 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
1943517 usd
us-gaap Interest Expense
InterestExpense
14595014 usd
us-gaap Interest Expense
InterestExpense
5742680 usd
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2000103 usd
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1490796 usd
us-gaap Management Fee Expense
ManagementFeeExpense
4123665 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
184698 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
172693 usd
us-gaap Professional Fees
ProfessionalFees
463115 usd
us-gaap Professional Fees
ProfessionalFees
556802 usd
CY2022Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
18904 usd
CY2021Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20164 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
56096 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
59836 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
551655 usd
CY2021Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
525211 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1290075 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1308659 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9771128 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
4152381 usd
us-gaap Operating Expenses
OperatingExpenses
22860199 usd
us-gaap Operating Expenses
OperatingExpenses
11791642 usd
CY2022Q3 us-gaap Other Operating Income
OtherOperatingIncome
250013 usd
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
186349 usd
us-gaap Other Operating Income
OtherOperatingIncome
806987 usd
us-gaap Other Operating Income
OtherOperatingIncome
515458 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9521115 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3966032 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22053212 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11276184 usd
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
10452439 usd
CY2021Q3 us-gaap Net Investment Income
NetInvestmentIncome
4909917 usd
us-gaap Net Investment Income
NetInvestmentIncome
28672542 usd
us-gaap Net Investment Income
NetInvestmentIncome
15143869 usd
CY2022Q3 cik0001794776 Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
-496697 usd
CY2021Q3 cik0001794776 Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
489555 usd
cik0001794776 Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
-1353321 usd
cik0001794776 Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
4335050 usd
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-496697 usd
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
489555 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1353321 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4335050 usd
CY2022Q3 cik0001794776 Noncontrolled Nonaffiliated Investments
NoncontrolledNonaffiliatedInvestments
-16711415 usd
CY2021Q3 cik0001794776 Noncontrolled Nonaffiliated Investments
NoncontrolledNonaffiliatedInvestments
-673345 usd
cik0001794776 Noncontrolled Nonaffiliated Investments
NoncontrolledNonaffiliatedInvestments
-102837812 usd
cik0001794776 Noncontrolled Nonaffiliated Investments
NoncontrolledNonaffiliatedInvestments
-4371638 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16711415 usd
CY2021Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-673345 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-102837812 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4371638 usd
CY2022Q3 cik0001794776 Total Realized And Unrealized Gainslosses
TotalRealizedAndUnrealizedGainslosses
-17208112 usd
CY2021Q3 cik0001794776 Total Realized And Unrealized Gainslosses
TotalRealizedAndUnrealizedGainslosses
-183790 usd
cik0001794776 Total Realized And Unrealized Gainslosses
TotalRealizedAndUnrealizedGainslosses
-104191133 usd
cik0001794776 Total Realized And Unrealized Gainslosses
TotalRealizedAndUnrealizedGainslosses
-36588 usd
CY2022Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-6755673 usd
CY2021Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
4726127 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-75518591 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
15107281 usd
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.45
CY2021Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.34
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
1.25
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
1.13
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.29
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.33
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.29
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.12
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23214683 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14429113 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22986437 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13431233 shares
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
10452439 usd
CY2021Q3 us-gaap Net Investment Income
NetInvestmentIncome
4909917 usd
us-gaap Net Investment Income
NetInvestmentIncome
28672542 usd
us-gaap Net Investment Income
NetInvestmentIncome
15143869 usd
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-496697 usd
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
489555 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1353321 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4335050 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16711415 usd
CY2021Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-673345 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-102837812 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4371638 usd
CY2022Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-6755673 usd
CY2021Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
4726127 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-75518591 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
15107281 usd
CY2022Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
10147434 usd
CY2021Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
3738707 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
18587402 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
7805916 usd
CY2022Q3 cik0001794776 Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
10147434 usd
CY2021Q3 cik0001794776 Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
3738707 usd
cik0001794776 Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
18587402 usd
cik0001794776 Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
7805916 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37227700 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4823801 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
45548774 usd
CY2022Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
5378541 usd
CY2021Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
2287446 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
10393371 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
6932158 usd
CY2022Q3 cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
5378541 usd
CY2021Q3 cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
39515146 usd
cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
15217172 usd
cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
52480932 usd
CY2022Q3 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-11524566 usd
CY2021Q3 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
40502566 usd
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-78888821 usd
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
59782297 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
385433333 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
272424702 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
452797588 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
253144971 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
373908767 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
312927268 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
373908767 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
312927268 usd
us-gaap Profit Loss
ProfitLoss
-75518591 usd
us-gaap Profit Loss
ProfitLoss
15107281 usd
cik0001794776 Non Affiliate Non Control Investments
NonAffiliateNonControlInvestments
-1353321 usd
cik0001794776 Non Affiliate Non Control Investments
NonAffiliateNonControlInvestments
4335050 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-102837812 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4371638 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
137874 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
171257 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
316620789 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
329327621 usd
cik0001794776 Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
227650962 usd
cik0001794776 Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
521946955 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
370814557 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
318059444 usd
cik0001794776 Proceeds From Sale Of Portfolio Investments
ProceedsFromSaleOfPortfolioInvestments
258148610 usd
cik0001794776 Proceeds From Sale Of Portfolio Investments
ProceedsFromSaleOfPortfolioInvestments
309397462 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
739152 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
541068 usd
cik0001794776 Increasedecrease In Receivable For Sales Of Investments
IncreasedecreaseInReceivableForSalesOfInvestments
-16756220 usd
cik0001794776 Increasedecrease In Receivable For Sales Of Investments
IncreasedecreaseInReceivableForSalesOfInvestments
-4424866 usd
cik0001794776 Increasedecrease In Interest And Dividends Receivable
IncreasedecreaseInInterestAndDividendsReceivable
1917162 usd
cik0001794776 Increasedecrease In Interest And Dividends Receivable
IncreasedecreaseInInterestAndDividendsReceivable
487143 usd
cik0001794776 Increasedecrease In Due From Investment Adviser
IncreasedecreaseInDueFromInvestmentAdviser
-30727 usd
cik0001794776 Increasedecrease In Due From Investment Adviser
IncreasedecreaseInDueFromInvestmentAdviser
30996 usd
cik0001794776 Increasedecrease In Receivable For Paydowns Of Investments
IncreasedecreaseInReceivableForPaydownsOfInvestments
2963237 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1093503 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
682579 usd
cik0001794776 Increasedecrease In Receivable For Paydowns Of Investments
IncreasedecreaseInReceivableForPaydownsOfInvestments
329260 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
204700 usd
cik0001794776 Increasedecrease In Interest Payable On Credit Facility
IncreasedecreaseInInterestPayableOnCreditFacility
-679066 usd
cik0001794776 Increasedecrease In Payable For Investments Purchased
IncreasedecreaseInPayableForInvestmentsPurchased
98194458 usd
cik0001794776 Increasedecrease In Payable For Investments Purchased
IncreasedecreaseInPayableForInvestmentsPurchased
-140655901 usd
cik0001794776 Increasedecrease In Management Fees Payable
IncreasedecreaseInManagementFeesPayable
245815 usd
cik0001794776 Increasedecrease In Management Fees Payable
IncreasedecreaseInManagementFeesPayable
-247975 usd
cik0001794776 Increasedecrease In Directors Fee Payable
IncreasedecreaseInDirectorsFeePayable
514 usd
cik0001794776 Increasedecrease In Directors Fee Payable
IncreasedecreaseInDirectorsFeePayable
-3586 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1323178 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2498945 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26582185 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61320116 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
77750000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
33017726 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
92000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2170127 usd
cik0001794776 Distributions Paid In Cash
DistributionsPaidInCash
14068712 usd
cik0001794776 Distributions Paid In Cash
DistributionsPaidInCash
4768228 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4823801 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
45548774 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23494911 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71628145 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3087274 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10308029 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4180777 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10990608 usd
us-gaap Interest Paid Net
InterestPaidNet
13915948 usd
us-gaap Interest Paid Net
InterestPaidNet
4951178 usd
cik0001794776 Distributions Declared Amount
DistributionsDeclaredAmount
18587402 usd
cik0001794776 Distributions Declared Amount
DistributionsDeclaredAmount
7805916 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
637100000 usd
cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
10393371 usd
cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
6932158 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Indemnifications</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2000000 usd
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2100000 usd
CY2021Q4 cik0001794776 Deferred Financing Costs
DeferredFinancingCosts
3400000 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1300000 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
649900000 usd
CY2022Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
700000 usd
CY2022Q3 cik0001794776 Deferred Financing Costs
DeferredFinancingCosts
2700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.90 pure
us-gaap Quarterly Financial Information Income Taxes Significant Variation Description
QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription
In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
CY2022Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1 pure
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Interest and Dividend Income Recognition</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Interest income is recorded on the accrual basis and includes amortization of premiums or accretion of discounts. Discounts and premiums to par value on securities purchased are accreted and amortized, respectively, into interest income over the contractual life of the respective security using the effective interest method. The amortized cost of investments represents the original cost adjusted for the amortization of premiums or accretion of discounts, if any. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees, paydown gains/losses and unamortized discounts are recorded as interest income in the current period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Accrued interest is generally reversed when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may make exceptions to this treatment and determine not to place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities and money market funds is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1 pure
cik0001794776 Annual Rate Of Average Value Of Weighted Average
AnnualRateOfAverageValueOfWeightedAverage
0.02 pure
cik0001794776 Management Fees Excess Rate
ManagementFeesExcessRate
0.0175 pure
cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Total
PercentageOfPortfolioInNonQualifyingAssetsTotal
0.148 pure
CY2021 cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Total
PercentageOfPortfolioInNonQualifyingAssetsTotal
0.133 pure
us-gaap Incentive Fee Description
IncentiveFeeDescription
The amount of the adjustment would be equal to the amount by which such net realized losses exceed such net investment income. On the other hand, if the Company’s net investment income over the most recently completed and three preceding calendar quarters is equal to or greater than the Company’s net realized losses over the same period, excluding the most recently completed quarter, then no adjustment to pre-incentive fee net investment income would be made. The Income Incentive Fee will be calculated and payable quarterly in arrears commencing with the first calendar quarter following a Listing. The Company will pay the Investment Advisor an Income Incentive Fee with respect to its “adjusted net investment income” in each calendar quarter as follows:   ● no Income Incentive Fee in any calendar quarter in which the Company’s “adjusted net investment income” does not exceed an amount equal to a “hurdle rate” of 1.5% per quarter (6% annualized) of the Company’s total net assets at the end of that quarter (the “Hurdle Amount”);     ● 100% of the Company’s “adjusted net investment income” with respect to that portion of such “adjusted net investment income,” if any, that exceeds the Hurdle Amount but is less than or equal to an amount (the “Catch-Up Amount”) determined on a quarterly basis by multiplying 1.6875% by the Company’s total net asset value for the immediately preceding calendar quarter. The Catch-Up Amount is intended to provide the Investment Advisor with an incentive fee of 12.5% on all of the Company’s “adjusted net investment income” when the Company’s “adjusted net investment income” reaches the Catch-Up Amount in any calendar quarter; and     ● for any calendar quarter in which the Company’s “adjusted net investment income” exceeds the Catch-Up Amount, the Income Incentive Fee shall equal 12.5% of the amount of the Company’s “adjusted net investment income” for the calendar quarter.  
CY2022Q3 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
1103805969 usd
CY2022Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1005512911 usd
CY2021Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
1189713653 usd
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1194257584 usd
cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Amortized Cost
PercentageOfPortfolioInNonQualifyingAssetsAmortizedCost
0.155 pure
cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Fair Value
PercentageOfPortfolioInNonQualifyingAssetsFairValue
0.154 pure
CY2021 cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Amortized Cost
PercentageOfPortfolioInNonQualifyingAssetsAmortizedCost
0.144 pure
CY2021 cik0001794776 Percentage Of Portfolio In Non Qualifying Assets Fair Value
PercentageOfPortfolioInNonQualifyingAssetsFairValue
0.145 pure
CY2022Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1005512911 usd
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1194257584 usd
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.56
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
803456 shares
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
15200000 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2551012 shares
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
52500000 usd
CY2022Q3 cik0001794776 Investment Company Unfunded Commitments
InvestmentCompanyUnfundedCommitments
4119933 usd
CY2021Q4 cik0001794776 Investment Company Unfunded Commitments
InvestmentCompanyUnfundedCommitments
11295718 usd
CY2022Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-6755673 usd
CY2021Q3 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
4726127 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-75518591 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
15107281 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23214683 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14429113 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22986437 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13431233 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.06
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.15
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.25
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.13
cik0001794776 Net Realized And Unrealized Gain Loss On Investments
NetRealizedAndUnrealizedGainLossOnInvestments
-4.5
cik0001794776 Net Realized And Unrealized Gain Loss On Investments
NetRealizedAndUnrealizedGainLossOnInvestments
-0.02
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-3.25
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.11
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.81
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.81
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.56
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16
CY2021Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.7
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
23373787 shares
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
15113817 shares
CY2022Q3 us-gaap Assets Net
AssetsNet
373908767 usd
CY2021Q3 us-gaap Assets Net
AssetsNet
312927268 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22986437 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13431233 shares
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1669 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0715 pure
cik0001794776 Portfolio Turnover
PortfolioTurnover
0.21 pure
cik0001794776 Portfolio Turnover
PortfolioTurnover
0.46 pure
us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0708 pure
us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0572 pure
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0683 pure
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0547 pure
us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0863 pure
us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0709 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0888 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0734 pure
CY2022Q3 cik0001794776 Distributions Payable
DistributionsPayable
usd
CY2022Q3 us-gaap Undistributed Earnings
UndistributedEarnings
usd
CY2021Q3 us-gaap Undistributed Earnings
UndistributedEarnings
usd
us-gaap Undistributed Earnings
UndistributedEarnings
usd
us-gaap Undistributed Earnings
UndistributedEarnings
usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
cik0001794776 Increasedecrease In Interest Payable On Credit Facility
IncreasedecreaseInInterestPayableOnCreditFacility
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13431233 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14429113 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22986437 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23214683 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.29
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001794776

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
cik0001794776-20220930_lab.xml Edgar Link unprocessable
cik0001794776-20220930_pre.xml Edgar Link unprocessable
0001213900-22-071147-index-headers.html Edgar Link pending
0001213900-22-071147-index.html Edgar Link pending
0001213900-22-071147.txt Edgar Link pending
0001213900-22-071147-xbrl.zip Edgar Link pending
cik0001794776-20220930.xsd Edgar Link pending
f10q0922ex31-1_palmersquare.htm Edgar Link pending
f10q0922ex31-2_palmersquare.htm Edgar Link pending
f10q0922ex32-1_palmersquare.htm Edgar Link pending
f10q0922ex32-2_palmersquare.htm Edgar Link pending
f10q0922_palmersquare.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
cik0001794776-20220930_cal.xml Edgar Link unprocessable
cik0001794776-20220930_def.xml Edgar Link unprocessable
f10q0922_palmersquare_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending